| P50 | author | Chia-Ron Yang | Q59692485 |
| P2093 | author name string | Robert K Yu | |
| P2860 | cites work | ASK1 is essential for endoplasmic reticulum stress-induced neuronal cell death triggered by expanded polyglutamine repeats | Q24298956 |
| | Clioquinol down-regulates mutant huntingtin expression in vitro and mitigates pathology in a Huntington's disease mouse model | Q24535603 |
| | Multiple effects of trehalose on protein folding in vitro and in vivo | Q27938229 |
| | Inhibition of caspase-1 slows disease progression in a mouse model of Huntington's disease | Q28114818 |
| | Huntingtin aggregation and toxicity in Huntington's disease | Q28204163 |
| | Protein Aggregation | Q58030632 |
| | Intraspinal delivery of neurotrophin-3 using neural stem cells genetically modified by recombinant retrovirus | Q78128999 |
| | Interference by huntingtin and atrophin-1 with cbp-mediated transcription leading to cellular toxicity | Q95721056 |
| | Neurodegenerative disorders of protein aggregation | Q28212108 |
| | Folding proteins in fatal ways | Q28235206 |
| | Multipotent neural cell lines can engraft and participate in development of mouse cerebellum | Q28290006 |
| | Impairment of the ubiquitin-proteasome system by protein aggregation | Q29614556 |
| | Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice | Q29615357 |
| | IAPs are essential for GDNF-mediated neuroprotective effects in injured motor neurons in vivo | Q30670979 |
| | Characterization of progressive motor deficits in mice transgenic for the human Huntington's disease mutation. | Q33857802 |
| | Minocycline inhibits caspase-1 and caspase-3 expression and delays mortality in a transgenic mouse model of Huntington disease | Q33908944 |
| | Glutamine repeats and neurodegeneration | Q33938576 |
| | Influence of molecular and chemical chaperones on protein folding | Q34432453 |
| | Stem cell therapy for human neurodegenerative disorders-how to make it work | Q35844778 |
| | Role of trehalose phosphate synthase and trehalose during hypoxia: from flies to mammals | Q35857970 |
| | Cell therapy in Huntington's disease. | Q36045364 |
| | Multipotent neural precursors can differentiate toward replacement of neurons undergoing targeted apoptotic degeneration in adult mouse neocortex | Q36605438 |
| | Age‐Dependent Striatal Excitotoxic Lesions Produced by the Endogenous Mitochondrial Inhibitor Malonate | Q36696707 |
| | Trehalose alleviates polyglutamine-mediated pathology in a mouse model of Huntington disease | Q38345839 |
| | Lesion of striatal neurons with kainic acid provides a model for Huntington's chorea | Q39109797 |
| | Scientific approaches to Huntington's disease | Q40081363 |
| | Experimental traumatic brain injury modulates the survival, migration, and terminal phenotype of transplanted epidermal growth factor receptor-activated neural stem cells. | Q40477461 |
| | Neural stem cells constitutively secrete neurotrophic factors and promote extensive host axonal growth after spinal cord injury | Q40643190 |
| | Protection against ischemic brain damage by GDNF affecting cell survival and death signals | Q40648835 |
| | Transplanted neural stem cells survive, differentiate, and improve neurological motor function after experimental traumatic brain injury | Q40703966 |
| | Stem cells in the central nervous system | Q41116811 |
| | Quinolinic acid: an endogenous metabolite that produces axon-sparing lesions in rat brain | Q41605555 |
| | Establishment and characterization of multipotent neural cell lines using retrovirus vector-mediated oncogene transfer | Q41741592 |
| | Neural stem cells spontaneously express dopaminergic traits after transplantation into the intact or 6-hydroxydopamine-lesioned rat. | Q44214555 |
| | Pivotal role of oligomerization in expanded polyglutamine neurodegenerative disorders. | Q44286601 |
| | Effects of systemic 3-nitropropionic acid-induced lesions of the dorsal striatum on cannabinoid and mu-opioid receptor binding in the basal ganglia. | Q44330257 |
| | Inhibition of insulin amyloid formation by small stress molecules | Q44849270 |
| | The cortical lesion of Huntington's disease: further neurochemical characterization, and reproduction of some of the histological and neurochemical features by N-methyl-D-aspartate lesions of rat cortex | Q45290847 |
| | Mitochondrial defect in Huntington's disease caudate nucleus | Q45291734 |
| | Specific caspase interactions and amplification are involved in selective neuronal vulnerability in Huntington's disease | Q45292219 |
| | Hyperactivity and hypoactivity in a rat model of Huntington's disease: the systemic 3-nitropropionic acid model | Q45295346 |
| | Early behavioral deficits in R6/2 mice suitable for use in preclinical drug testing | Q45298349 |
| | Aggregation in Huntington's disease: insights through modelling | Q45299452 |
| | Trehalose, a novel mTOR-independent autophagy enhancer, accelerates the clearance of mutant huntingtin and alpha-synuclein. | Q45303665 |
| | Brain transplantation of genetically engineered human neural stem cells globally corrects brain lesions in the mucopolysaccharidosis type VII mouse | Q45869109 |
| | Brain transplantation of neural stem cells cotransduced with tyrosine hydroxylase and GTP cyclohydrolase 1 in Parkinsonian rats | Q45883914 |
| | Engraftable human neural stem cells respond to developmental cues, replace neurons, and express foreign genes. | Q45890216 |
| | Stem cells act through multiple mechanisms to benefit mice with neurodegenerative metabolic disease. | Q46695611 |
| | Human neural stem cell transplantation promotes functional recovery in rats with experimental intracerebral hemorrhage | Q48244314 |
| | Differentiation of engrafted multipotent neural progenitors towards replacement of missing granule neurons in meander tail cerebellum may help determine the locus of mutant gene action. | Q48617389 |
| | Histopathological and behavioral improvement of murine mucopolysaccharidosis type VII by intracerebral transplantation of neural stem cells. | Q50469125 |
| | Reestablishment of damaged adult motor pathways by grafted embryonic cortical neurons. | Q50666206 |
| | Prolonged intracerebroventricular infusion of neurosteroids affects cognitive performances in the mouse. | Q51413132 |
| | Behavioral characterization of the Tg2576 transgenic model of Alzheimer's disease through 19 months. | Q52012764 |
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| | ImageQuant | Q112270642 |
| P433 | issue | 1 | |
| P921 | main subject | pathology | Q7208 |
| | Huntington's disease | Q190564 |
| | alpha,alpha-trehalose | Q421773 |
| | neural stem cell | Q2944097 |
| | stem cell transplantation | Q65592366 |
| P304 | page(s) | 26-33 | |
| P577 | publication date | 2009-01-01 | |
| P1433 | published in | Journal of Neuroscience Research | Q6295654 |
| P1476 | title | Intracerebral transplantation of neural stem cells combined with trehalose ingestion alleviates pathology in a mouse model of Huntington's disease | |
| P478 | volume | 87 | |